K263-0012 Screening compound: {[3-(4-methylphenyl)-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl]sulfanyl}methyl cyanide

K263-0012 Screening compound: {[3-(4-methylphenyl)-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl]sulfanyl}methyl cyanide
K263-0012 Screening compound: {[3-(4-methylphenyl)-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl]sulfanyl}methyl cyanide alternative view

Chemical Structure Depiction of ChemDiv screening compound K263-0012
{[3-(4-methylphenyl)-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl]sulfanyl}methyl cyanide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K263-0012

Molecular Formula

C19H13N3OS2 (C19 H13 N3 OS2)

Compound Name

{[3-(4-methylphenyl)-4-oxo-3,4-dihydro[1]benzothieno[3,2-d]pyrimidin-2-yl]sulfanyl}methyl cyanide

IUPAC name

2-{[5-(4-methylphenyl)-6-oxo-8-thia-35-diazatricyclo[7.4.0.0^{27}]trideca-1(13)2(7)3911-pentaen-4-yl]sulfanyl}acetonitrile

SMILES

Cc(cc1)ccc1N(C1=O)C(SCC#N)=Nc2c1sc1c2cccc1

InChI

InChI=1S/C19H13N3OS2/c1-12-6-8-13(9-7-12)22-18(23)17-16(21-19(22)24-11-10-20)14-4-2-3-5-15(14)25-17/h2-9H,11H2,1H3

InChI Key

IAABSKCAOZSRQO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15085308

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

363.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.074

Distribution Coefficient, logD

4.074

Water Solubility, LogSw

-4.12

Polar Surface Area

41.418

Acid Dissociation Constant (pKa)

28.80

Base Dissociation Constant (pKb)

1.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.50

K263-0012 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with K263-0012 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K263-0012?
Check Price and Availability of K263-0012, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K263-0012 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K263-0012
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K263-0012
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K263-0012 available by request